These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 2151564)

  • 21. Experience with full-dose hepatitis B vaccine in Wellington Hospital staff.
    Humble MW; Maddocks PA
    N Z Med J; 1985 Jun; 98(781):479-81. PubMed ID: 3159979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low dose hepatitis B vaccination of hospital staff.
    Allwood GK; Barnes WJ
    N Z Med J; 1985 Oct; 98(788):866. PubMed ID: 2932663
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of the immunogenicity of hepatitis B vaccine administered intradermally and intramuscularly.
    King JW; Taylor EM; Crow SD; White MC; Todd JR; Poe MB; Conrad SA; Gelder FB
    Rev Infect Dis; 1990; 12(6):1035-43. PubMed ID: 2148433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibodies against hepatitis B after vaccination in health workers].
    Pérez-López JA; García-Elorriaga G; Del Rey-Pineda G; Manjarrez-Téllez B
    Salud Publica Mex; 2011; 53(3):205-6. PubMed ID: 21829884
    [No Abstract]   [Full Text] [Related]  

  • 25. Active immunization against hepatitis B virus (HBV) with low-doses of plasma-derived vaccine by intradermal route.
    Carrilho FJ; Queiroz ML; da Silva LC; da Fonseca LE; Granato C; Oba I; Obara L
    Rev Inst Med Trop Sao Paulo; 1989; 31(2):91-4. PubMed ID: 2602806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of higher-dose intradermal hepatitis B vaccination to standard intramuscular vaccination of healthcare workers.
    Henderson EA; Louie TJ; Ramotar K; Ledgerwood D; Hope KM; Kennedy A
    Infect Control Hosp Epidemiol; 2000 Apr; 21(4):264-9. PubMed ID: 10782589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intradermal hepatitis B vaccine in thalassaemia and sickle cell disease.
    Mok Q; Underhill G; Wonke B; Aldouri M; Kelsey M; Jefferies D
    Arch Dis Child; 1989 Apr; 64(4):535-40. PubMed ID: 2526622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal by intradermal hepatitis B vaccination of unresponsiveness to HBsAg.
    Nagafuchi S; Kashiwagi S
    Lancet; 1987 Dec; 2(8574):1522-3. PubMed ID: 2892077
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy and long-term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: A prospective study in healthcare personnel.
    Kalchiem-Dekel O; Grupel D; Bouchnik L; Sikuler E; Ben-Yakov G
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1782-7. PubMed ID: 26101816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccine choice and program participation rates when two hepatitis B vaccines are offered.
    Harris AA; Daly-Gawenda D; Hudson EK
    J Occup Med; 1991 Jul; 33(7):804-7. PubMed ID: 1832443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low dose hepatitis B vaccination in children: benefit of low dose boosters.
    Milne A; Moyes CD; Dimitrakakis M
    N Z Med J; 1988 Jun; 101(847 Pt 1):370-1. PubMed ID: 2970604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune response to intramuscular revaccination after primary intradermal vaccination against hepatitis B.
    Pegues DA; Woodruff BA; Lambert SB; Tant MK; Woernle CH
    Clin Infect Dis; 1995 Feb; 20(2):335-41. PubMed ID: 7742439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody response to heat-inactivated hepatitis B vaccine (CLB-3 micrograms) in hemodialysis patients and occupational risk personnel: a one year follow-up.
    Yoshida FT; Takahashi C; Mercadante LA; Camargo IF; Schatzmayr HG
    Rev Inst Med Trop Sao Paulo; 1988; 30(1):11-6. PubMed ID: 2975824
    [No Abstract]   [Full Text] [Related]  

  • 34. Dose range study in healthy volunteers of a hepatitis B vaccine produced in yeast.
    Kuwert E; Scheiermann N; Gesemann M; Paar D; Safary A; Simoen E; Hauser P; Andre F
    Antiviral Res; 1985; Suppl 1():281-8. PubMed ID: 2935080
    [No Abstract]   [Full Text] [Related]  

  • 35. Long term observation of the effect of intradermal hepatitis B vaccination on mentally retarded patients.
    Hayashi J; Noguchi A; Nakashima K; Morofuji M; Kashiwagi S
    Eur J Epidemiol; 1991 Nov; 7(6):649-53. PubMed ID: 1838338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of the intradermal route of hepatitis B vaccination with the use of recombinant hepatitis B vaccine.
    Lancaster D; Elam S; Kaiser AB
    Am J Infect Control; 1989 Jun; 17(3):126-9. PubMed ID: 2742197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Humoral immunity level and factors associated with the response to the vaccine against the hepatitis B virus in health personnel of the Case-Essalud National Hospital, Arequipa September 1995-March 2002].
    Campos Nizama J
    Rev Gastroenterol Peru; 2005; 25(2):141-9. PubMed ID: 16021199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost effectiveness of intradermal vs. subcutaneous hepatitis B vaccination for the mentally handicapped.
    Hayashi J; Nakashima K; Noguchi A; Morofuji M; Kashiwagi S
    J Infect; 1991 Jul; 23(1):39-45. PubMed ID: 1832182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vaccination against hepatitis B in the Sarajevo Military Hospital].
    Ler Z
    Vojnosanit Pregl; 1991; 48(3):201-5. PubMed ID: 1835220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical setting.
    Sangfelt P; Uhnoo I; Reichard O; Weiland O
    Scand J Gastroenterol; 2008; 43(4):465-72. PubMed ID: 18365912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.